comparemela.com

Page 2 - Remix Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032)

Small Molecule Immunomodulators Market Size will Expand to

Bone Biologics (BBLG) Appoints Robert E Gagnon to its Board

Bone Biologics (BBLG) Appoints Robert E Gagnon to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bone Biologics Appoints Healthcare Finance Veteran Robert E Gagnon to Board of Directors

Bone Biologics Appoints Healthcare Finance Veteran Robert E Gagnon to Board of Directors
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

Remix tunes up for 2024 with potential $1B Roche deal, $60M financing

With its launch barely three years in the rearview mirror, Remix Therapeutics Inc. has inked its second potential $1 billion pharma collaboration, drawing Roche Holding AG to the table with the promise of its RNA processing platform and the potential to develop small-molecule therapeutics targeting the underlying drivers of disease. At the same time, the Cambridge, Mass.-based firm added $60 million in a venture round, bringing its total financing to date to $201 million.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.